About 400 reports

  • GROWING PREFERENCE FOR CHEMOTHERAPY DRUGS IN DEVELOPING COUNTRIES
  • Disease overview
  • Chemotherapy
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • Helsinn Group
  • Merck & Co., Inc.
  • 2.7.2 Chemotherapy-Induced Neutropenia
  • 2.3.6 Chemotherapy-Induced Neutropenia
  • Chemotherapy
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Epidemiology: Chemotherapy-Induced Anemia
  • GASTRIC CANCER CASES ON CHEMOTHERAPY
  • Chemotherapy
  • Europe
  • Japan
  • Amgen Inc.
  • Galenica Group

Chemotherapy Induced Neutropenia- Epidemiology Forecast to 2027 ##.

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Spain

Chemotherapy Induced Anemia - Epidemiology Forecast to 2027 ##.

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Spain

Chemotherapy Induced Nausea and Vomiting - Epidemiology Forecast to 2027 ##.

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Spain

Chemotherapy Induced Anemia : ##MM Market Analysis ##. ##. ##MM Market Size of Chemotherapy Induced Anemia ##. ##. ##MM Percentage Share of drugs marketed for Chemotherapy Induced Anemia ##. ##. ##MM Market Sales of Chemotherapy Induced Anemia by Products ##.

  • Blood Disease
  • Chemotherapy
  • Oncology
  • Pathology
  • Therapy

Chemotherapy Induced Nausea and Vomiting : ##MM Market Analysis ##. ##. ##MM Market Size of Chemotherapy Induced Nausea and Vomiting ##. ##. ##MM Percentage Share of drugs marketed for Chemotherapy Induced Nausea and Vomiting ##. ##. ##MM Market Sales of Chemotherapy Induce

  • Chemotherapy
  • Therapy

Chemotherapy Induced Neutropenia (CIN): ##MM Market Analysis ##. ##. ##MM Market Size of Chemotherapy Induced Neutropenia (CIN) ##. ##. ##MM Percentage Share of drugs marketed for Chemotherapy Induced Neutropenia (CIN) ##. ##. ##MM Market Sales of Chemotherapy Induced Neutr

  • Chemotherapy
  • Oncology
  • Therapy

Chemotherapy Induced Neutropenia- Epidemiology Insights to 2023 Report Introduction Snapshot of Total Prevalent or Incident cases by ## MM Executive Summary Key Findings Chemotherapy Induced Neutropenia Overview Chemotherapy Induced Neutropenia Definition Pathophysiology S

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Japan

Neupogen (Filgrastim), developed and marketed by Amgen is the first G-CSF approved for chemotherapy-induced neutropenia (CIN) in 1991.

  • Chemotherapy
  • France
  • Germany
  • Italy
  • United Kingdom
  • Chemotherapy-induced neutropenia
  • Chemotherapy-induced anemia
  • Blood Disease
  • Chemotherapy
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.
  • Chemotherapy
  • 51.45% of the market share comes from chemotherapy
  • Chemotherapy
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Chemotherapy
  • Availability of chemotherapy and off-label drugs
  • Chemotherapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.
  • CHEMOTHERAPY
  • Global Kaposi sarcoma chemotherapy market 2016-2021 ($ millions)
  • Chemotherapy
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • AVERAGE COST PER CYCLE OF CHEMOTHERAPY REGIMENS IN THE 8MM
  • SHOWS THE AVERAGE COST PER CYCLE OF CHEMOTHERAPY REGIMENS IN THE 8MM.
  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • 8.4 EFFECTIVE ALTERNATIVES TO CHEMOTHERAPY
  • AVERAGE COST OF THERAPY OF GENERIC CHEMOTHERAPY IN THE 8MM
  • Chemotherapy
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Occurs within 24 hours of chemotherapy
  • MARKET SEGMENTATION BYDISEASE ONSET
  • Chemotherapy
  • GlaxoSmithKline plc
  • Helsinn Group
  • Heron Therapeutics, Inc.
  • Merck & Co., Inc.
  • Export of Unilateral Chemotherapy Drug
  • Import of Unilateral Chemotherapy Drug
  • Chemotherapy
  • Therapy
  • China
  • Trade
  • Lilly Pharmaceutical China Inc
  • 6.6 CHEMOTHERAPIES
  • SUMMARY OF CHEMOTHERAPIES, 2015
  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • SAFETY OF GUADECITABINE IN ELDERLY PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
  • EFFICACY OF GUADECITABINE + CHEMOTHERAPY IN ELDERLY NEWLY DIAGNOSED AML
  • Chemotherapy
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Celgene Corporation
  • Novartis AG
  • Import of Unilateral Chemotherapy Drug
  • Export of Unilateral Chemotherapy Drug
  • Chemotherapy
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.
  • Chemotherapy Drugs
  • CHEMOTHERAPY DRUGS SALES AND FORECASTS (BILLION
  • Cardiovascular Drug
  • Chemotherapy
  • China
  • Demand
  • Market Size
  • Chemotherapy Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume (Million Yuan)
  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Import of Chemotherapy Drug
  • Chemotherapy Drug Sales Volume and Market Share
  • Chemotherapy
  • China
  • Demand
  • Market Size
  • Trade
  • Import of Chemotherapy Drug
  • Chemotherapy Drug Sales Volume and Market Share
  • Chemotherapy
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.
  • UROLOGIC ONCOLOGY, OPTIMAL AND ACTUAL CHEMOTHERAPY USAGE RATES ACROSS ALL
  • 2.6 Treatment
  • Chemotherapy
  • World
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Chemotherapy Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume (Million Yuan)
  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Chemotherapy Drugs Sales Volume (million Yuan)
  • Chemotherapy Drugs Sales Volume by Drugs Classification in 2016(percent)
  • Chemotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Chemotherapy Drugs Sales Volume (million Yuan)
  • Chemotherapy Drugs Sales Volume by Drugs Classification in 2016(percent)
  • Chemotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd